Eli Lilly's experimental drug retatrutide helped Type 2 diabetes patients lose up to 16.8% of their body weight in a Phase 3 trial, topping all rivals ...

Researchers found that the risk of type 2 diabetes varies among young adults. Those with high fasting glucose who qualified for GLP-1 treatment had a higher risk of type 2 diabetes, suggesting that ...

Type 2 diabetes is one of the most prevalent problems modern society faces. Previously referred to as “adult-onset diabetes,” ...

If adolescents replaced 30 minutes of sedentary time each day with sleep or moderate-to-vigorous physical activity, it may ...

Researchers found that fatty pancreas was observed to vary in different populations. The study published in the European ...